BRIEF-Redhill Biopharma Ltd and IntelGenx announce RIZAPORT commercialization with pharmatronic co.

Wed Sep 21, 2016 8:19am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Sept 21 (Reuters) - Redhill Biopharma Ltd :

* Redhill Biopharma and IntelGenx announce RIZAPORT commercialization term sheet with Pharmatronic Co. for Korea

* Pursuant to signing of definitive agreement, Co will grant Pharmatronic exclusive rights to commercialize RIZAPORT in South Korea

* Under term sheet, Co and IntelGenx are to receive an upfront payment and will be eligible to receive additional milestone payments

* Financial terms of term sheet were not disclosed Source text for Eikon: Further company coverage: